Clinical Trials Directory

Trials / Completed

CompletedNCT05289739

Exercise Training in Childhood Cancer

Get Strong to Fight Childhood Cancer: An Exercise Intervention for Children and Adolescents Undergoing Anti-Cancer Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
478 (actual)
Sponsor
Johannes Gutenberg University Mainz · Academic / Other
Sex
All
Age
4 Years – 21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this multicenter study is to evaluate a personalised and standardised exercise intervention for children and adolescents undergoing anti-cancer treatment.

Detailed description

In the randomised, controlled FORTEe trial, high evidence for an innovative, patient-centred exercise treatment shall be generated. Supervised exercise training intents to increase muscle strength and reduce muscular atrophy due to bedrest. CRF and HRQoL can be improved and in the future, these benefits may help to fight childhood cancer by increasing therapy efficiency and survival rate. Within the project, digital, innovative technologies such as augmented reality will be developed and applied to make the exercise training more effective, age-adapted and personalised. Moreover, FORTEe will stimulate translational research to provide access to paediatric exercise oncology as a new health care intervention. As a progress beyond the current state-of-the-art, FORTEe has the ambition to implement paediatric exercise oncology as an evidence-based standard in clinical care for all childhood cancer patients across the EU and beyond.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExercise trainingExercise training during intensive cancer treatment. Training mainly consists of age-appropriate and personalized endurance, strength, flexibility, balance/coordination and gait training. Three to five weekly training sessions lasting 30 to 60 minutes each for about eight to ten weeks (depending on the course of the cancer treatment).

Timeline

Start date
2022-04-25
Primary completion
2026-01-26
Completion
2026-01-26
First posted
2022-03-21
Last updated
2026-02-09

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05289739. Inclusion in this directory is not an endorsement.